
On January 31, the Rosselkhoznadzor will hold a meeting with the unions and associations of market participants dedicated to the execution by the supply countries requirements for the non-use of ractopamine in the production of meat products intended for deliveries to the market of Russia and other countries of the Customs Union.
Rectopamine is a substance used as a feed additive to increase muscle mass in pigs and cattle. The ractopamine was approved by the US Food and Drug Products (FDA) in 1999 (and the Canadian CFIA, Canadian Food Inspection Agency, under the Paylean® trademark in 2005) for lead use, and in early 2003 for cattle. Rectopamine is the product of Elanco, owned by Eli Lilly and is sold in the USA and Canada called Paylean - for pigs and OPTAFLEXX - for use by cattle.
Employees of livestock farms note that Paylean is poorly reflected in the health and behavior of animals: they become aggressive in relation to each other and to a person, arthritis develops, lose their ability to cope with stresses and may even fall dead from a heart attack during any stressful situation.
The consumption of animal meat, which was fed with a ractopamine, can cause poisoning that manifests itself in such clinical signs as heart rhythm disturbances, tremors, headaches, muscle spasms, and increasing blood pressure. The action on a person is not fully studied.
Currently, it is widely used in the USA, Brazil, Mexico, and other countries. Forbidden to use in the countries of the European Union, China, Russia, etc.
In October 2011, the Rosselkhoznadzor notified the main exporters of meat to Russia of the inadmissibility of the use of ractopamine in meat and the need to provide certificates confirming its absence. In December 2012, the norms came into force by which the shipment of pork and beef is possible only after the product is checked for the presence of ractopamine. In response, the US authorities made a statement of Russia of violating obligations when joining the WTO.